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Background and aims: A single nucleotide polymorphism of A118G (SNP; rs1799971) in the opioid receptor μ-1
(OPRM1) gene is a missense variant that inﬂuences the afﬁnity of μ-opioid receptors. This study aimed to investigate
the associations among the A118G polymorphism in the OPRM1 gene, psychiatric symptoms, and quantitative
electroencephalography (qEEG) ﬁndings in patients with gambling disorder. Methods: Fifty-ﬁve male patients with
gambling disorder aged between 18 and 65 years old participated in the study. The A118G polymorphism was
genotyped into the AA, GA, and GG groups by the polymerase chain reaction/restriction fragment length
polymorphism method. Resting-state qEEG was recorded with the eyes closed, and the absolute power of the delta
(1–4 Hz), theta (4–8 Hz), alpha (8–12 Hz), and beta (12–30 Hz) frequency bands was analyzed. Psychiatric
symptoms, including depression, anxiety, impulsivity and severity of gambling, were assessed by a self-rating scale.
Results: There were no signiﬁcant differences in psychiatric symptoms among the three genotype groups (AA, GA,
and GG). However, the frequency band power of qEEG showed signiﬁcant differences among the three genotype
groups. The absolute power of the beta and theta bands in the frontal lobe was higher in G allele carriers. Discussion
and conclusion: Based on the ﬁndings of this study, the polymorphism in the OPRM1 gene might affect the
neurophysiological process in patients with gambling disorder.
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INTRODUCTION
Although gambling is a popular leisure activity, pathologi-
cal gambling is associated with impairments of social
function, such as reduced quality of life, legal problems,
bankruptcy, divorce, and incarceration (Argo & Black,
2004). The estimated past-year and lifetime prevalence of
gambling disorder are approximately 0.2%–0.3% and
0.4%–1.0% of the general population, respectively
(American Psychiatric Association [APA], 2013).
Pathological gambling was categorized into the Impulse-
Control Disorders Not Elsewhere Classiﬁed section in
Diagnostic and Statistical Manual of Mental Disorders
(DSM-IV) due to its impulsive characteristics (APA,
2000). However, recent neurobiological studies found sim-
ilarities in brain structures and functions between subjects
with pathological gambling and substance use disorder
(Grant, Potenza, Weinstein, & Gorelick, 2010; Leeman &
Potenza, 2012; Potenza, 2008). Thus, pathological gambling
was renamed as gambling disorder and included in the
Substance-Related and Addictive Disorders section in
DSM-5 (APA, 2013). Substance use disorder is the most
comorbid disorder with pathological gambling (Lorains,
Cowlishaw, & Thomas, 2011).
Endogenous opioids such as β-endorphins and enkepha-
lins are central neurotransmitters in addictive disorders.
Opioids bind to μ-opioid receptors (MOPRs) in GABAergic
interneurons in the ventral tegmental area, which is a reward
processing pathway (Mague & Blendy, 2010). The binding
of opioids results in the release of dopamine (DA) in the
nucleus accumbens, which is associated with reinforcement
and addiction (Di Chiara & Imperato, 1988). MOPRs are
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essential components of the opioid system, and a deﬁciency
in these receptors is associated with altered behaviors and
dependence (Matthes et al., 1996).
A single nucleotide polymorphism (SNP; rs1799971) in
the opioid receptor μ-1 (OPRM1) gene is a missense variant
that inﬂuences the afﬁnity of MOPR. A transition from A to
G on nucleotide 118 (A118G) encodes the substitution of an
amino acid from asparagine to aspartate (ASP) in codon 40
(Bergen et al., 1997). A polymorphism in the OPRM1
gene was originally reported to inﬂuence the function of
MOPRs, such as afﬁnity of the receptor. The polymorphism
causes a threefold increase in the binding afﬁnity
for β-endorphin (Bond et al., 1998). Furthermore, it alters
the signal transduction cascade and receptor levels
(Mura et al., 2013).
The OPRM1 gene is most widely studied in association
with substance use disorder (Pfeifer et al., 2015; Rouvinen-
Lagerström et al., 2013). The results of studies on the
associations between the OPRM1 gene polymorphism and
substance use disorder have been inconsistent. For instance,
some studies reported signiﬁcant associations between alcohol
dependence and the A118G polymorphism (Bart et al., 2005;
Nishizawa et al., 2006; Rommelspacher, Smolka, Schmidt,
Samochowiec, & Hoehe, 2001), whereas other studies did not
report associations (Bergen et al., 1997; Loh, Fann, Chang,
Chang, & Cheng, 2004). A recent meta-analysis reported did
not report a strong association between the A118G polymor-
phism and alcohol dependence due to limitations of hetero-
geneities and small sample sizes (Kong et al., 2017).
Several studies have reported the associations between the
rs1799971 SNP and clinical outcomes in subjects with a
heroin addiction. The polymorphism was associated with
long-term abstinence from heroin without treatment (Levran
et al., 2017) and consequences related to heroin use, such as
unexpected reactions or overdose (Woodcock, Lundahl,
Burmeister, & Greenwald, 2015). Although Arias, Feinn,
and Kranzler (2006) did not identify an association between
the polymorphism in theOPRM1 gene and the risk of general
substance dependence, a recent meta-analysis showed that no
relationship was observed in African or Caucasian
populations, but was observed in Asian populations (Haerian
& Haerian, 2013). Similarly, the polymorphism affects other
substance addictions, such as nicotine addiction (Verhagen,
Kleinjan, & Engels, 2012).
Although opioid antagonists, such as nalmefene and
naltrexone, have been studied for the treatment of gambling
disorder (Grant et al., 2006), there is no study on the direct
association between the OPRM1 gene polymorphism and
gambling disorder. A study of gambling disorder treated
with naltrexone investigated the treatment effect with the
interaction of the A118G polymorphism and reported that
patients with the AA genotype showed increased emotional
well-being (Kovanen et al., 2016).
Electroencephalography (EEG) is an electrophysiologi-
cal monitoring tool used to assess the electrical activity of
the brain, and quantitative electroencephalography (qEEG)
includes an analysis of the power spectra of the delta
(1–4 Hz), theta (4–8 Hz), alpha (8–12 Hz), and beta
(12–30 Hz) frequency bands. Most research on the EEG
correlates of gambling has focused on reward sensitivities
and decision-making in gambling tasks and suggests that the
feedback negativity event-related potential is sensitive to
outcome expectation (Houston & Ceballos, 2013).
However, no study has addressed the association
between resting-state qEEG and the A118G SNP in patients
with gambling disorder. Thus, this study aimed to
investigate the associations among psychopathology, band
power spectrum of resting-state qEEG, and OPRM1 gene
polymorphism in gambling disorder.
METHODS
Study setting, data sources, and sample
Individuals who visited the gambling disorder clinic in a
university hospital, South Korea, were considered for inclu-
sion in the study. The inclusion criteria were diagnosis of
gambling disorder according to DSM-5 criteria, male
gender, and age between 18 and 65 years old. Subjects
were excluded if any of the following applied: a diagnosis of
substance use disorder other than nicotine and caffeine
based on DSM-5; use of psychotropic medications over
the last year; and the presence of a physical, mental disorder,
or neurological disorder. Based on the inclusion and
exclusion criteria, 55 male subjects (age: 38.42± 11.59
years) were enrolled in this study. None of the participants
were taking any medications, and all had completed at least
12 years of education (14.65± 1.89 years).
Measures
Psychosocial variables. Psychosocial variables were
assessed with the following validated self-rating scales:
Beck Depression Inventory for depression, Beck Anxiety
Inventory for anxiety, Barratt Impulsiveness Scales for
impulsivity, Lubben Social Network Scale for social
networks, Wender–Utah Attention Deﬁcit/Hyperactivity
Disorder Rating Scale for childhood attention-deﬁcit/
hyperactivity symptoms, the 9-item Problem Gambling
Severity Index from the Canandian Problem Gambling
Index, and the Gambling Symptom Assessment Scale for
the severity of gambling disorder.
DNA analysis. Approximately 10 ml of ethylenediamine-
tetraacetic acid-treated venous blood was obtained for DNA
extraction from each subject. Genomic DNA was extracted
from blood samples by standard methods (Lahiri &
Schnabel, 1993). The A118G polymorphism was genotyped
using the polymerase chain reaction/restriction fragment
length polymorphism method described by Gelernter,
Kranzler, and Cubells (1999).
EEG recording and preprocessing. EEG recordings were
performed using a SynAmps2 direct current (DC) ampliﬁer
and a 10–20 layout 64-channel Quick-Cap electrode-
placement system (Neuroscan Inc., NC, USA). EEG data
were digitally recorded from 19 gold cup electrodes placed
according to the international 10–20 system. Impedances
were maintained below 5 kΩ, and the sampling rate was
1,000 Hz. We used the linked mastoid reference and two
additional bipolar electrodes to measure horizontal and
vertical eye movements. During the recording, each
participant laid in a semidarkened, electrically shielded,
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sound-attenuated room. A resting EEG was recorded after
3 min having the participant’s eyes closed.
We used MATLAB 7.0.1 (Math Works, Natick, MA,
USA) and the EEGLAB toolbox (Delorme &Makeig, 2004)
to preprocess and analyze EEG recordings. First, EEG data
were downsampled to 250 Hz. Next, EEG data were
detrended and mean-subtracted to remove the DC
component. A 1-Hz high-pass ﬁlter and 60-Hz notch ﬁlter
were applied to remove the eye and electrical noise. Next,
independent component analysis (ICA) was performed to
remove well-deﬁned sources of artifacts. ICA has been
demonstrated to reliably isolate artifacts caused by eye and
muscle movements and heart noise (Jung et al., 2000).
Finally, clinical psychiatrists and EEG experts visually
inspected the corrected EEGs. For the analysis, we selected
more than 2 min of artifact-free EEG readings from 3-min
recordings.
EEG analysis. Four frequency bands were deﬁned for
further analysis, delta (1–4 Hz), theta (4–8 Hz), alpha
(8–12 Hz), and beta (12–30 Hz). We investigated the
power spectra of the EEG data from each subject using
the short-time Fourier transform “spectrogram.m” function
from the Signal Processing Toolbox in MATLAB. A time
window of 1,000 ms with an 800-ms overlap and Hamming
window were used for the spectral analysis. Outliers that
were far from the spectral value distribution of each
frequency band at the 0.05 signiﬁcance level were
removed. Finally, the absolute power was averaged over
all of the time windows and frequency bands for further
analysis.
Statistical analyses
We divided OPRM1 A118G into the AG, GG, and AA
genotype groups. Analysis of variance (ANOVA) across the
genotype was used to test group differences in
demographic, clinical characteristics, and EEG data. The
homogeneity of slopes between the groups was ﬁrst
assessed using Levene’s test to follow-up tests at individual
electrodes. If the slopes were homogeneous, a second step
was performed using one-way ANOVA to compare the
activity recorded at each individual electrode among the
three groups. Statistical signiﬁcance was deﬁned as
p< .05. We used the false discovery rate (FDR) correction,
in which p values were multiplied by the number of compar-
isons, to control false positives in multiple comparisons. We
used Bonferroni-corrected post-hoc comparisons for three
groups to determine speciﬁc group differences (p< .0167).
All data were analyzed using Statistical Package for the
Social Sciences (SPSS) statistical software, version 18.0
(SPSS Inc., Chicago, IL, USA).
Ethics
This study was approved by the Institutional Review Board
of the Eulji Medical Center (Seoul, South Korea; NSU-
161220-01) and was performed in accordance with the
Declaration of Helsinki. All participants submitted written
informed consent after receiving a complete description of
the study and were not compensated for their participation in
the study.
RESULTS
Demographic and clinical characteristics
The total sample comprised 55 male individuals with
gambling disorder [mean age (SD)= 38.42 (11.59) years].
Twenty-three subjects had the AA genotype, 20 had the GA
genotype, and 12 had the GG genotype. No deviation from
Hardy–Weinberg equilibrium was observed in this study
population (χ2= 0.03, p= .99). There were no differences in
demographic data and clinical characteristics between the
genotype groups. Demographic and clinical characteristics
are summarized in Table 1.
QEEG activity
Theta and delta absolute power. Theta absolute power
exhibited signiﬁcant differences among the genotypes. After
the Bonferroni correction of post-hoc comparisons, the AA
Table 1. Demographic and clinical characteristics of subjects
Subject (n)
AA GA GG
F p value23 20 12
Age (years) 37.17± 10.51 40.00± 13.14 38.17± 11.50 0.313 .732
Education (year) 14.26± 2.03 14.70± 2.08 15.33± 0.98 1.296 .282
BDI 15.30± 10.20 19.45± 9.47 14.50± 7.01 1.456 .243
BAI 12.78± 9.47 12.50± 11.21 12.33± 7.96 0.009 .991
BIS 58.43± 7.46 55.10± 9.93 54.75± 6.37 1.186 .313
LSNS 24.96± 4.56 24.25± 5.86 25.00± 6.25 0.112 .894
WURS 30.57± 17.11 29.90± 18.08 29.42± 8.61 0.022 .978
CPGI-PGIS 18.30± 7.02 19.50± 5.83 18.92± 5.37 0.195 .824
GSAS 23.74± 14.32 26.75± 9.56 16.67± 10.46 2.688 .077
Note. Analysis of variance and post hoc test were used. Data are given as mean± standard deviation. BDI: Beck Depression Inventory; BAI:
Beck Anxiety Inventory; BIS: The Korean version of Barratt Impulsiveness Scale; LSNS: Lubben Social Network Scale; WURS: Wender–
Utah Rating Scale; CPGI-PGIS: Canadian Problem Gambling Index–Problem Gambling Severity Index; GSAS: Gambling Symptom
Assessment Scale.
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genotype showed lower power in the theta frequency than
the GG genotype at 7 of the electrodes (Fp1, Fp2, Fz, F4, F8,
Cz, and C4). There was a signiﬁcant difference at the Fp2
electrode between the GA and GG genotypes (GA<GG),
but there were no signiﬁcant differences between the AA
and GA genotypes. All signiﬁcant differences were
FDR-corrected (Figure 1). Delta absolute power also exhib-
ited signiﬁcant differences in a focal region of F8.
Beta absolute power. Beta absolute power showed sig-
niﬁcant differences among the genotypes. After the Bon-
ferroni correction of the post-hoc comparisons, the AA
genotype showed lower power in the beta frequency than
the GG genotype at 9 of the electrodes (Fp1, Fp2, F7, F3, Fz,
F4, F8, Cz, and C4). Four of the electrodes (Fp1, Fp2, F3,
and Fz) exhibited signiﬁcant differences between the GA
and GG genotypes, but there were no signiﬁcant differences
between the AA and GA genotypes. All signiﬁcant differ-
ences were FDR-corrected (Figure 1). Figure 2 shows the
scalp topographies of the three groups in terms of the
absolute power in each band.
DISCUSSION
This study investigated the associations between the power
spectrum of EEG frequency bands and the μ-opioid
polymorphism A118G in patients with gambling disorder.
All of the participants in this study were Korean (Asian) and
58.2% of participants carried the 118G allele (n= 32). This
ﬁnding is in consistent with a previous study in which the
118G (ASP40) allele showed the lowest frequencies in
Africans (<5%) and the highest frequencies (25%–45%) in
Asians (Arias et al., 2006). Moreover, other studies analyzing
Korean alcohol-dependent patients reported a percentage of
carriers of 118G allele ranging from 54% to 67% (Kim, Kim,
Song, et al., 2004; Kim, Kim, Kang, et al., 2004).
Figure 1. Absolute EEG power in theta and beta bands during the resting-state condition. The horizontal bars represent standard errors.
*Signiﬁcant difference in the post-hoc test with the Bonferroni correction (p< .0167)
Figure 2. The topographic maps representing the probability of analysis of variance among groups. Scale show μV2 for absolute power. A
colored area means an increase of difference in absolute powers
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The psychiatric symptoms assessed by self-rating scales,
such as depression, anxiety, impulsivity, and severity of
gambling, were not signiﬁcantly different among the three
OPRM1 polymorphism groups. Although there are no
studies on the direct association of the psychopathology of
gambling disorder and A118G polymorphism, these results
seem consistent with previous studies that reported no
association between the OPRM1 gene polymorphism and
substance dependence, including heroin and alcohol (Arias
et al., 2006; Kong et al., 2017).
In contrast to psychiatric symptoms, the frequency band
power of qEEG showed signiﬁcant differences among the
three groups. In carriers of the 118G allele, the absolute
power of the beta and theta bands in the frontal lobe was
higher in patients without the 118G allele. These results are
interesting and suggest that the polymorphism in the
OPRM1 gene might alter the neurophysiological processes
of patients with gambling disorder, although the subjective
psychiatric symptoms do not differ.
Increased absolute power of the theta and delta bands
(slow wave) in the frontal area is a common ﬁnding in
patients with psychiatric disorders, such as attention-
deﬁcit/hyperactivity disorder (ADHD), intermittent explosive
disorder, and substance use disorders, which are characterized
by impulsivity (Hanaﬁah, Taib, & Hamid, 2010; Kamarajan
& Porjesz, 2012; Rangaswamy et al., 2003; Tye, Rijsdijk, &
McLoughlin, 2014). Increased theta power might be associ-
ated with dopaminergic function. Catechol-O-methyl-
transferase (COMT) is an enzyme that metabolizes DA, and
the COMT gene Val158Met SNP was reportedly associated
with theta power (Lee et al., 2011). The COMT gene Val
variant degrades DA at up to four times the rate of the Met
variant and results in reduced synaptic DA. According to Lee
et al. (2011), healthy females with the Val variant showed
increased theta power in the frontal and central regions. The
binding of opioids toMOPRs induces the release of DA in the
reward circuit (Heinz et al., 2009). Furthermore, the OPRM1
polymorphism alters addictive behavior and striatal DA
concentrations in a mouse model (Zhang et al., 2015), and
changes in the DA pathway were identiﬁed with increased
theta power in the frontal cortex (Jang, Kim, Kim, & Lee,
2009). Thus, the increased theta power observed in patients
carrying the G allele suggests that differences in the binding
afﬁnity of the MOPR caused by the polymorphism in the
OPRM1 gene might be associated with altered theta power
related to the dopaminergic system.
In this study, patients carrying the G allele also showed
higher absolute power in the beta band than patients without
the G allele. Despite some studies regarding the EEG corre-
lates of gambling behavior using a “gambling task,” few
studies have addressed EEG band power among pathologic
gamblers (Houston & Ceballos, 2013). However, across the
majority of “impulsive spectrum disorders” similar to
gambling disorder, including substance abuse disorders,
conduct disorder, ADHD, antisocial personality disorder, and
eating disorder, the major EEG ﬁnding is excessive beta
power in resting status (Kamarajan & Porjesz, 2012).
Increased power of beta bands may reﬂect a hyperexcitable
state that is produced by an excitation–inhibition imbalance
mediated by GABAergic synaptic potentials (Faulkner,
Traub, & Whittington, 1999; Rangaswamy et al., 2002).
For instance, increased beta bands are also a characteristic
feature in alcoholism (Kamarajan & Porjesz, 2012). Previous
studies have indicated decreased levels of GABA-
benzodiazepine receptors in alcoholics (Abi-Dargham
et al., 1998; Lingford-Hughes et al., 1998). The associations
between the GABA receptor gene and the EEG beta band
have been established (Porjesz et al., 2002). GABAergic
interneurons maintain inhibition of dopaminergic neurons
(Pecin˜a, Love, Stohler, Goldman, & Zubieta, 2015). The
binding of opioids to MOPRs decreases this inhibition and
results in the release of DA from the GABAergic interneuron
(Johnson & North, 1992; Mague & Blendy, 2010). This
phasic release of DA is considered to contribute to substance
dependence (Wise & Bozarth, 1985). An increased beta band
in patients with the G allele indicates that differences in the
binding afﬁnity of the MOPR according to the OPRM1 gene
polymorphism might be associated with the GABAergic
system. Consequently, together with differences in the theta
band, the polymorphism in the OPRM1 gene polymorphism
might be associated with alterations in the DA system.
This study has several limitations that should be noted.
First, this study did not include healthy controls, which
limit the comparison between the patients and controls as
well as a generalized interpretation of our ﬁndings for
normal populations. Our small sample size is another
shortcoming of this study. Future studies including healthy
controls and a larger sample are needed to conﬁrm the
present ﬁndings. Second, this study used only a self-rating
scale to assess psychiatric symptoms and the severity of
pathological gambling. Pathological gamblers often have
poor insight, which might cause incorrect reports of psy-
chiatric symptoms or the severity of gambling. Potentially,
the lack of signiﬁcant differences in depression, anxiety,
impulsivity and severity of gambling among the three
groups in this study resulted from inaccurate self-reporting.
Thus, reports from multiple informants, including partici-
pants’ families, could improve the reliability of the assess-
ment for the psychiatric symptoms of participants. In
addition, some neuropsychological tests could provide
more accurate information about a patient’s cognition and
impulsivity. Future studies, including multi-informant
reports and neuropsychological tests, could reveal more
subtle differences in psychological aspects related to the
OPRM1 gene and qEEG.
Despite some limitations, to our knowledge, this is the
ﬁrst study to investigate the association between OPRM1
gene polymorphism and qEEG frequency band power in
pathological gambling. In this study, the absolute power of
the beta and theta bands in the frontal and central regions
was increased in patients carrying the G allele compared
with patients without the G allele, and the increased power
was not closely associated with psychiatric symptoms or the
severity of gambling. Our ﬁndings will help to extend the
understanding of the neurophysiologic changes related to
OPRM1 gene polymorphism.
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